LMR Partners LLP

Position in DXCM — Dexcom Inc

CIK 1578621 LONDON, X0

Position in DXCM

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$217,675

-$19,192,925 QoQ

Shares Held

3,232

-99.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#712

of 971 holders

Holding Since

Sep 2020

15 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

LMR Partners LLP holds $176,676,753 across 16 Medical Devices names. DXCM ranks #14 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PEN	Penumbra Inc	213,893	$67,536,714
2	SNN	Smith & Nephew PLC	1,767,872	$50,932,392
3	MDT	Medtronic plc	308,551	$24,137,944
4	PRCT	PROCEPT BioRobotics Corp	721,608	$16,293,908
5	ALMR	Alamar Biosciences, Inc.	175,000	$4,740,750
6	BSX	Boston Scientific Corp	107,478	$4,587,160
7	SYK	Stryker Corp	9,604	$3,023,723
8	EW	Edwards Lifesciences Corp	25,155	$2,275,521

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$217,675	3,232	-99.0%	Shares	Other	2026-08-14
2026-03-31	$19,410,600	309,086	+101.6%	Shares	Sole	2026-05-15
2024-12-31	$11,924,007	153,324	+180.6%	Shares	Sole	2025-02-14
2024-03-31	$7,578,568	54,640	+598.0%	Shares	Sole	2024-05-15
2023-12-31	$971,376	7,828	-47.2%	Shares	Sole	2024-02-14
2023-09-30	$1,383,452	14,828	-80.3%	Shares	Sole	2023-11-14
2023-03-31	$8,727,906	75,124	-23.5%	Shares	Sole	2023-05-15
2022-12-31	$11,118,242	98,183	+31.8%	Shares	Sole	2023-02-14
2022-09-30	$6,000,230	74,500	-7.6%	Shares	Sole	2022-11-14
2022-06-30	$6,009,577	80,633	+317.1%	Shares	Sole	2022-08-15
2022-03-31	$9,889,228	19,330	+66.0%	Shares	Sole	2022-05-16
2021-12-31	$6,253,319	11,646	+2296.3%	Shares	Sole	2022-02-14
2021-09-30	$265,773	486	-85.8%	Shares	Sole	2021-11-15
2021-06-30	$1,459,059	3,417	-65.2%	Shares	Sole	2021-08-16
2020-09-30	$4,050,159	9,825	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.